Unclaimed Scholar Profile
Are you Anil Pooran? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at African Institute for Mathematical SciencesASIDASID-3201-6442-1531 orcid.org/0000-0001-5808-433X
Anil Pooran
African Institute for Mathematical Sciences
Faculty researcher at African Institute for Mathematical Sciences (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Tuberculosis Research and Epidemiology#Infectious Diseases and Tuberculosis#Immune responses and vaccinations#Diagnosis and treatment of tuberculosis
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 7,628 | 3,661 |
| h-index | 23 | 17 |
| i10-index | 31 | 22 |
Annual Citation Growth
Verified Citations / Year0
2020366
2021+40%513
2022+28%659
2023+33%879
2024-8%805
2025-45%439
2026Scholarship Distribution & Proportions58 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:25% African Regional Citations (1,907) • 75% Global Research Impact (5,721)
58 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (58)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
Published in The Lancet Respiratory Medicine•2022
DOI: 10.1016/s2213-2600(22)00092-3 Verified Peer-Reviewed
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
Published in The Lancet•2014
DOI: 10.1016/s0140-6736(13)62675-6 Verified Peer-Reviewed
What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
Published in PLoS ONE•2013
DOI: 10.1371/journal.pone.0054587 Verified Peer-Reviewed
Showing 1 – 5 of 58 publications
1 / 12